Primary Job Title President and Chief Executive Officer, co-founder and Board Member Primary Organization 
Nuclea Biotechnologies
Gender Male
Mr. Muraca was formerly the President and Chief Operating Officer of Clinomics Biosciences, Inc. and Vice President of Cytogenetic Diagnostics for Oncor, Inc.
While at Oncor, Mr. Muraca was instrumental in obtaining Food and Drug Administration (FDA) approval for the HER-2neu test kit, the first gene-based breast cancer test approved by the
FDA. Mr. Muraca has over sixteen years of experience in the development of life science technology, including the development of microscopic-based digital imaging technology.
Mr. Muraca graduated from Clark University in Worcester, Massachusetts. He has approximately twenty scientific abstracts and publications concentrating in the area of new biomarkers in cancer. He is also a named inventor on approximately twenty US and international utility and design patents.
Mr. Muraca is currently an affiliate member of the American College of Medical Genetics and a member of the American Association of Tissue Banks. He is also currently a board member of the Jimmy Fund Council of the Berkshires.
